Global Cold-Chain Pharma Market Outlook Report 2022-2027 : Compound Annual Growth of 12% Predicted, with Market Set to Reach $12,574 Million by 2027 – ResearchAndMarkets.com

Global Cold-Chain Pharma Market Outlook Report 2022-2027 : Compound Annual Growth of 12% Predicted, with Market Set to Reach $12,574 Million by 2027 - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cold-chain Pharma Market Research Report by Pharma Product, Services, Temperature Range, Transportation, Region – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Cold-chain Pharma Market size was estimated at USD 6,291.22 million in 2021, USD 7,044.91 million in 2022, and is projected to grow at a CAGR of 12.23% to reach USD 12,574.89 million by 2027.

The report categorizes the Cold-chain Pharma to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Pharma Product, the market was studied across Biologics, Over-the-Counter Medicines, Prescribed Drugs, and Raw Materials & Bulk Pharmaceuticals.

Based on Services, the market was studied across Transportation and Warehousing and VAS.

Based on Temperature Range, the market was studied across Ambient and Refrigerated. The Refrigerated is further studied across Frozen, Liquid-Phase Liquid Nitrogen Conditions, Ultra-Frozen,, and Vapour-Phase Liquid Nitrogen.

Based on Transportation, the market was studied across Air-ways, Road, and Sea-ways.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia. This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cold-chain Pharma market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles, including:

Agility Public Warehousing

AmerisourceBergen

Cavalier Logistics

Continental AG

Deutsche Post DHL Group

FedEx Corp.

JWD InfoLogistics Public

Kerry Logistics Network

Kuehne + Nagel International

LifeConEx

OOCL Logistics

Orient Overseas International

SCG Logistics Management

United Parcel Service Inc.

VersaCold Logistics Services

The report provides insights on the following:

Market Penetration

Market Development

Market Diversification

Competitive Assessment & Intelligence

Product Development & Innovation

The report answers questions such as:

1. What is the market size and forecast of the Global Cold-chain Pharma Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cold-chain Pharma Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cold-chain Pharma Market?

4. What is the competitive strategic window for opportunities in the Global Cold-chain Pharma Market?

5. What are the technology trends and regulatory frameworks in the Global Cold-chain Pharma Market?

6. What is the market share of the leading vendors in the Global Cold-chain Pharma Market?

7. What modes and strategic moves are considered suitable for entering the Global Cold-chain Pharma Market?

For more information about this report visit https://www.researchandmarkets.com/r/rxgggz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.